SCHEMBL18003003

SCHEMBL18003003

O=Cc1cccc(-c2cnc3ccccn23)c1

nearest known ligand 0.56

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MIF P14174 1/20 0.56
DYRK1A Q13627 4/20 0.55
DYRK1B Q9Y463 4/20 0.55
DYRK2 Q92630 3/20 0.55
DYRK3 O43781 2/20 0.55
CCNT1 O60563 2/20 0.55
CDK9 P50750 2/20 0.55
CDK5 Q00535 2/20 0.55
CDK5R1 Q15078 2/20 0.55
FLT3 P36888 4/20 0.52
PIK3CA P42336 2/20 0.47
KDR P35968 4/20 0.47
PRMT5 O14744 1/20 0.45
WDR77 Q9BQA1 1/20 0.45
CDK1 P06493 1/20 0.43
CDK4 P11802 1/20 0.43
CDK2 P24941 1/20 0.43
IRAK4 Q9NWZ3 1/20 0.42
CHEK1 O14757 1/20 0.42
MAP4K4 O95819 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14852518 0.81 DYRK1A (0.56) DYRK1ADYRK1BDYRK2DYRK3CCNT1
SCHEMBL2650330 0.78 FLT3 (0.74) MIFDYRK1ADYRK1BFLT3PIK3CA
SCHEMBL73247 0.78 BACE1 (0.62) MIFDYRK1ADYRK1BDYRK2DYRK3
SCHEMBL29109646 0.78 FLT3 (0.69) MIFDYRK1ADYRK1BFLT3PIK3CA
SCHEMBL73445 0.78 MIF (0.60) MIFDYRK1ADYRK1BDYRK2DYRK3
SCHEMBL14138786 0.78 MIF (0.60) MIFDYRK1ADYRK1BFLT3PIK3CA
SCHEMBL30655418 0.78 FLT3 (0.69) MIFDYRK1ADYRK1BFLT3PIK3CA
SCHEMBL23330745 0.76 FLT3 (0.51) MIFDYRK1AFLT3PIK3CAKDR
SCHEMBL16675756 0.74 MIF (0.59) MIFFLT3CHEK1
SCHEMBL72363 0.74 IRAK4 (0.61) MIFDYRK1ADYRK1BFLT3PIK3CA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4219477-A1 CYANOTRIAZOLE COMPOUNDS Otsuka Pharmaceutical Co., Ltd. (JP) 2023-08-02 EP disclosed
US-10626095-B2 Cyanotriazole compounds OTSUKA PHARMACEUTICAL CO., LTD. (JP) 2020-04-21 US disclosed
US-20160229816-A1 CYANOTRIAZOLE COMPOUNDS OTSUKA PHARMACEUTICAL CO., LTD. (JP) 2016-08-11 US disclosed
US-20160229816-A1 CYANOTRIAZOLE COMPOUNDS OTSUKA PHARMACEUTICAL CO., LTD. (JP) 2016-08-11 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10626095-B2 Cyanotriazole compounds CS, PC, ACAT1 MIF 2367/4885DYRK1A 3453/4885DYRK1B 3272/4885
US-20160229816-A1 CYANOTRIAZOLE COMPOUNDS CS, PC, ACAT1 MIF 2367/4885DYRK1A 3453/4885DYRK1B 3272/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.